Heppe Medical Chitosan

supplies pharmaceutical-grade chitosan and custom chitosan oligomers under GMP conditions to European drug developers and researchers.

Country
Germany
pharma-grade eu
Coverage
CNEUUS
fibers-textiles
Regulatorsfdaefsareach

Verifiable facts

FactValueSource
FundingThe company received seed funding in 2008 and a second financing round in 2010 led by KI Kapital and High-Tech Gründerfonds, raising a total of $790,000.caplight.com · htgf.de
CapacityThe company operates a state-of-the-art production facility in Germany with modular production equipment, clean room class C for production, and clean room class A for filling small batches.gmp-chitosan.com
CertificationThe company is ISO 9001 and ISO 13485 (including ISO 22442) certified.gmp-chitosan.com · chemeurope.com
Regulatory approvalThe company has an active Drug Master File (DMF) Class IV for excipients for its ultrapure chitosan hydrochloride series with the US FDA since 2016.gmp-chitosan.com
Production siteThe company's production facility is located in Halle (Saale), Germany.gmp-chitosan.com · chemeurope.com
HeadcountThe company employs approximately 5 people.caplight.com · startbase.com
RevenueSpecific revenue figures are not publicly disclosed. medium confidencenorthdata.de

Independent sources: caplight.com · chemeurope.com · gmp-chitosan.com · htgf.de · northdata.de · startbase.com

Technologies
NameClusterRisk
Chitin & chitosanfibers-textilesMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.